Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease

Journal of Pediatrics

Volumn 161, Issue 3, 2012, Pages

  Tremoulet, Adriana H ^a   Pancoast, Paige ^a   Franco, Alessandra ^a   Bujold, Matthew ^a   Shimizu, Chisato ^a   Onouchi, Yoshihiro ^b   Tamamoto, Alyson ^c   Erdem, Guliz ^c   Dodd, Debra ^d   Burns, Jane C ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b RIKEN   (Japan)

^c KAPIOLANI MEDICAL CENTER FOR WOMEN AND CHILDREN   (United States)

^d MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CASPASE 3; CYCLOSPORIN A; FC RECEPTOR IIA; IMMUNOGLOBULIN; INFLIXIMAB; INOSITOL TRISPHOSPHATE 3 KINASE; INOSITOL TRISPHOSPHATE 3 KINASE C; MAGNESIUM; METHYLPREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE OTITIS MEDIA; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CORONARY ARTERY ANEURYSM; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FEVER; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG SAFETY; DRUG SPECIFICITY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL HEMORRHAGE; GENETIC RISK; GENOTYPE; HIRSUTISM; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; IMMUNOTHERAPY; INFANT; INFLAMMATION; LYMPHOCYTE COUNT; MALE; MEMORY T LYMPHOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PHENOTYPE; PNEUMATOSIS INTESTINALIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; SUPPLEMENTATION; TARGET CELL; TREATMENT RESPONSE;

EID: 84865315517     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2012.02.048     Document Type: Article

References (40)

1. A.H. Tremoulet, B.M. Best, S. Song, S. Wang, E. Corinaldesi, and J.R. Eichenfield Resistance to intravenous immunoglobulin in children with Kawasaki disease J Pediatr 153 2008 117 121
2. J.C. Burns, E.V. Capparelli, J.A. Brown, J.W. Newburger, M.P. Glode US/Canadian Kawasaki Syndrome Study Group Intravenous gamma-globulin treatment and retreatment in Kawasaki disease Pediatr Infect Dis J 17 1998 1144 1148 (Pubitemid 29023891)
3. R. Uehara, E.D. Belay, R.A. Maddox, R.C. Holman, Y. Nakamura, and M. Yashiro Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan Pediatr Infect Dis J 27 2008 155 160
4. T.J. Brown, S.E. Crawford, M.L. Cornwall, F. Garcia, S.T. Shulman, and A.H. Rowley CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease J Infect Dis 184 2001 940 943 (Pubitemid 32881104)
5. A. Franco, C. Shimizu, A.H. Tremoulet, and J.C. Burns Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease Autoimmunity 43 2010 317 324
6. D.J. Schulte, A. Yilmaz, K. Shimada, M.C. Fishbein, E.L. Lowe, and S. Chen Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease J Immunol 183 2009 5311 5318
7. + T cells in coronary artery lesions in patients with Kawasaki disease Exp Mol Pathol 83 2007 93 103 (Pubitemid 46842967)
8. T.T. Duong, E.D. Silverman, M.V. Bissessar, and R.S. Yeung Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease Int Immunol 15 2003 79 89 (Pubitemid 36163770)
9. K. Takahashi, T. Oharaseki, T. Nagao, Y. Yokouchi, H. Yamada, and N. Nagi-Miura Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease Pediatr Rheumatol 9 2011 30
10. Y. Onouchi, K. Ozaki, J.C. Buns, C. Shimizu, H. Hamada, and T. Honda Common variants in CASP3 confer susceptibility to Kawasaki disease Hum Mol Genet 19 2010 2898 2906
11. Y. Onouchi, Y. Suzuki, H. Suzuki, M. Terai, K. Yasukawa, and H. Hamada ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease Pharmacogenom J 2011 Epub ahead of print
12. H.C. Kuo, H.R. Yu, S.H. Juo, K.D. Yang, Y.S. Wang, and C.D. Liang CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children J Hum Genet 56 2011 161 165
13. A.F. Freeman, and S.T. Shulman Refractory Kawasaki disease Pediatr Infect Dis J 23 2004 463 464 (Pubitemid 38621487)
14. C.C. Khor, S. Davila, W.B. Breunis, Y.C. Lee, C. Shimizu, and V.J. Wright Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease Nat Genet 43 2011 1241 1246
15. K. Asano, T. Matsushita, J. Umeno, N. Hosono, A. Takahashi, and T. Kawaguchi A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population Nat Genet 41 2009 1325 1329
16. P. Bruhns, B. Iannascoli, P. England, D.A. Mancardi, N. Fernandez, and S. Jorieux Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses Blood 113 2009 3716 3725
17. H. Suzuki, M. Terai, H. Hamada, T. Honda, T. Suenaga, and T. Takeuchi Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin Pediatr Infect Dis J 30 2011 871 876
18. D. Colombo, and C.G. Egan Bioavailability of Sandimmun® versus Sandimmun Neoral®: a meta-analysis of published studies Int J Immunopathol Pharmacol 23 2010 1177 1183
19. R. Gusmano, G.C. Basile, F. Perfumo, F. Ginevri, E. Verrina, and L. Famlaro Pharmacokinetics of oral cyclosporine microemulsion formulation (Neoral) in children awaiting renal transplantation Transplant Proc 30 1998 1985 1987 (Pubitemid 28399398)
20. J.W. Newburger, M. Takahashi, M.A. Gerber, M.H. Gewitz, L.Y. Tani, and J.C. Burns Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation 110 2004 2747 2771 (Pubitemid 39453026)
21. C. Manlhiot, K. Millar, F. Golding, and B.W. McCrindle Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease Pediatr Cardiol 31 2010 242 249
22. D. Burgner, S. Davila, W.B. Breunis, S.B. Ng, Y. Li, and C. Bonnard A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease PLoS Genet 5 2009 e1000319
23. J.W. Newburger, M. Takahashi, A.S. Beiser, J.C. Burns, J. Bastian, and K.J. Chung A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome N Engl J Med 324 1991 1633 1639
24. J.C. Burns, B.M. Best, A. Mejias, L. Mahony, D.E. Fixler, and H.S. Jafri Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease J Pediatr 153 2008 833 838
25. V. Raman, J. Kim, A. Sharkey, and T. Chatila Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy Pediatr Infect Dis J 20 2001 635 637 (Pubitemid 32567732)
26. M. Mori Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin Nippon Rinsho 66 2008 349 354 (in Japanese)
27. T.W. Kuijpers, M. Biezeveld, A. Achterhuis, I. Kuipers, J. Lam, and C.E. Hack Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect Pediatrics 112 2003 986 992 (Pubitemid 37248716)
28. D.A. Wright, J.W. Newburger, A. Baker, and R.P. Sundel Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids J Pediatr 128 1996 146 149 (Pubitemid 26028974)
29. T. Kobayashi, Y. Inoue, T. Otani, A. Morikawa, T. Kobayashi, and K. Takeuchi Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease Pediatr Infect Dis J 28 2009 498 502
30. G. Koren, and S.M. MacLeod Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease J Pediatr 105 1984 991 995 (Pubitemid 15185335)
31. G. Koren Salicylates in Kawasaki disease: a review of clinical pharmacokinetics and efficacy Prog Clin Biol Res 250 1987 415 424
32. Lexi-Comp Online. Pediatric & Neonatal Lexi-Drugs Online. Available at http://online.lexi.com/crlsql/servlet/crlonline. Accessed January 3, 2012.
33. F. Citterio Evolution of the therapeutic drug monitoring of cyclosporine Transplant Proc 36 2004 420S 425S (Pubitemid 38373902)
34. A. Schrauder, S. Saleh, K.W. Sykora, H. Hoy, K. Welte, and J. Boos Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients: the trough level is not enough Pediatr Transplant 13 2009 444 450
35. M. Cantarovich, J.S. Barkun, J.I. Tchervenkov, J.G. Besner, L. Aspeslet, and P. Metrakos Comparison of neoral dose monitoring with cyclosporine through levels versus 2-hr postdose levels in stable liver transplant patients Transplantation 66 1998 1621 1627 (Pubitemid 29034981)
36. U. Herden, A. Kromminga, C. Hagel, J. Hartleb, B. Nashan, and M. Sterneck Monitoring of nuclear factor of activated T-cell-regulated gene expression in de novo and long-term liver transplant recipients treated with cyclosporine A Ther Drug Monit 33 2011 185 191
37. Y. Onouchi, T. Gunji, J.C. Burns, C. Shimizu, J.W. Newburger, and M. Yashiro ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms Nat Genet 40 2008 35 42
38. F. Macian NFAT proteins: key regulators of T-cell development and function Nat Rev Immunol 5 2005 472 484
39. W. Wu, R.S. Misra, J.Q. Russell, R.A. Flavell, M. Rincon, and R.C. Budd Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3 J Biol Chem 281 2006 10682 10690 (Pubitemid 43855489)
40. 1000 Genome Consortium. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-73.